Pyxis Oncology PYXS
NASDAQ PYXS
$1.64 +0.01 (+0.61%)
At close: Nov 11, 2026 · 4:00 PM EST

Pyxis Oncology (PYXS) Preferred Stock Liabilities (2020 - 2021)

Updated

Pyxis Oncology (PYXS) posted Preferred Stock Liabilities of $172.08 million for Q3 2021, up 684.3% from $21.94 million a year earlier but down 11.3% from the prior quarter.

Analysis

Pyxis Oncology (PYXS) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Pyxis Oncology's Preferred Stock Liabilities came in at $43.88 million.

  • Quarterly Preferred Stock Liabilities has run from a low of $21.94 million in Q3 2020 to a high of $194.02 million in Q2 2021 over five years.
  • According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $194.02 million (Q2 2021), $194.02 million (Q1 2021) and $43.88 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Pyxis Oncology 136.12 Mn -60.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 172.08 Mn
Jun 30, 2021 194.02 Mn
Mar 31, 2021 194.02 Mn
Dec 31, 2020 43.88 Mn
Sep 30, 2020 21.94 Mn
API Access

Pyxis Oncology Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PYXS&period=max&api_key=YOUR_API_KEY